These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 11086104)

  • 1. Activated human T lymphocytes express a functional C3a receptor.
    Werfel T; Kirchhoff K; Wittmann M; Begemann G; Kapp A; Heidenreich F; Götze O; Zwirner J
    J Immunol; 2000 Dec; 165(11):6599-605. PubMed ID: 11086104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3a(desArg) does not bind to and signal through the human C3a receptor.
    Wilken HC; Götze O; Werfel T; Zwirner J
    Immunol Lett; 1999 Apr; 67(2):141-5. PubMed ID: 10232396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons.
    Gutzmer R; Lisewski M; Zwirner J; Mommert S; Diesel C; Wittmann M; Kapp A; Werfel T
    Immunology; 2004 Apr; 111(4):435-43. PubMed ID: 15056381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes.
    Martin U; Bock D; Arseniev L; Tornetta MA; Ames RS; Bautsch W; Köhl J; Ganser A; Klos A
    J Exp Med; 1997 Jul; 186(2):199-207. PubMed ID: 9221749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor.
    Honczarenko M; Ratajczak MZ; Nicholson-Weller A; Silberstein LE
    J Immunol; 2005 Sep; 175(6):3698-706. PubMed ID: 16148115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement C3a binding to its receptor as a negative modulator of Th2 response in liver injury in trichloroethylene-sensitized mice.
    Wang F; Zha WS; Zhang JX; Li SL; Wang H; Ye LP; Shen T; Wu CH; Zhu QX
    Toxicol Lett; 2014 Aug; 229(1):229-39. PubMed ID: 24974766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin.
    Kirchhoff K; Weinmann O; Zwirner J; Begemann G; Götze O; Kapp A; Werfel T
    Immunology; 2001 Jun; 103(2):210-7. PubMed ID: 11412308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
    Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
    J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
    Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
    FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of rat C3a receptor: differential expression of rat C3a and C5a receptors by LPS stimulation.
    Fukuoka Y; Ember JA; Hugli TE
    Biochem Biophys Res Commun; 1998 Jan; 242(3):663-8. PubMed ID: 9464274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen.
    Kawamoto S; Yalcindag A; Laouini D; Brodeur S; Bryce P; Lu B; Humbles AA; Oettgen H; Gerard C; Geha RS
    J Clin Invest; 2004 Aug; 114(3):399-407. PubMed ID: 15286806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.
    Fukuoka Y; Ember JA; Hugli TE
    J Immunol; 1998 Sep; 161(6):2977-84. PubMed ID: 9743361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.
    Boos L; Campbell IL; Ames R; Wetsel RA; Barnum SR
    J Immunol; 2004 Oct; 173(7):4708-14. PubMed ID: 15383607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
    Ames RS; Lee D; Foley JJ; Jurewicz AJ; Tornetta MA; Bautsch W; Settmacher B; Klos A; Erhard KF; Cousins RD; Sulpizio AC; Hieble JP; McCafferty G; Ward KW; Adams JL; Bondinell WE; Underwood DC; Osborn RR; Badger AM; Sarau HM
    J Immunol; 2001 May; 166(10):6341-8. PubMed ID: 11342658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.
    Gasque P; Singhrao SK; Neal JW; Wang P; Sayah S; Fontaine M; Morgan BP
    J Immunol; 1998 Apr; 160(7):3543-54. PubMed ID: 9531317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
    Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
    J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U-937 cells.
    Crass T; Raffetseder U; Martin U; Grove M; Klos A; Köhl J; Bautsch W
    Eur J Immunol; 1996 Aug; 26(8):1944-50. PubMed ID: 8765043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies.
    Zwirner J; Götze O; Begemann G; Kapp A; Kirchhoff K; Werfel T
    Immunology; 1999 May; 97(1):166-72. PubMed ID: 10447728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of C3a receptor attenuates the development of diabetic nephropathy.
    Li XQ; Chang DY; Chen M; Zhao MH
    BMJ Open Diabetes Res Care; 2019; 7(1):e000817. PubMed ID: 31798904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.